Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Macular Degeneration × salicylhydroxamic acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Myocardial Reperfusion Injury 2 Cardiotoxicity 2 Vomiting 1 Uveal Melanoma 1 Retinal Diseases 1 Pain, Postoperative 1 Nausea 1 Melanoma 1 Macular Degeneration 1 Lung Neoplasms 1 Kidney Neoplasms 1 Choroid Diseases 1 Breast Neoplasms 1

Interventions

salicylhydroxamic acid 1 brolucizumab 1 aflibercept 1 Triamcinolone Acetonide 1 Ranibizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00811200 2009-07-02

TORR

Leiden University Medical Center

Phase 2/3 Unknown

Uveal Melanoma, Macular Degeneration, Melanoma, Retinal Diseases, Choroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡